Amraph India Private Limited

Amraph India Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51496DL1996PTC075523 Incorporated 18 January 1996 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2024
₹4.01 Cr
▲ 31% YoY
Net profit · FY 2024
₹1.09 Lakh
Net margin 0.3%
EBITDA · FY 2024
₹14.43 Lakh
EBITDA margin 3.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10.18 Lakh
Secured borrowings
Company age
30 yrs
Est. 1996
Directors on board
2
As per MCA filings

About Amraph India Private Limited

Data last updated:

Amraph India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 18 January 1996 and has been in existence for over 30 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51496DL1996PTC075523. Its GSTIN is 07AAACA9872B1ZS (Delhi).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar Kaushik and Neeru Kaushik.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/4 Lalita Park Laxmi Nagar, New Delhi, Delhi, India – 110092.

As per the financials filed for FY 2024, the company reported a revenue of ₹4.01 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹1.09 Lakh (net margin 0.3%) and EBITDA of ₹14.43 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 6% over five years.

As per MCA filings, the company has open charges of ₹10.18 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Amraph India Private Limited
CIN U51496DL1996PTC075523
Registration Number 075523
Incorporation Date 18 January 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    1/4 Lalita Park Laxmi Nagar, New Delhi, Delhi, India – 110092
  • Industry
    Healthcare, Medical Equipment Retail & Distribution
Comprehensive company report
Amraph India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Amraph India Private Limited report

Financials, compliance, directors, charges, ownership and filings for Amraph India Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Amraph India Private Limited

The main business activity of Amraph India is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Amraph India Private Limited FY 2025 filings available

Amraph India Private Limited reported revenue of ₹4.01 Cr (up 31% YoY) for FY 2024.

Revenue · FY 2024
₹4.01 Cr ▲ 31%
Net profit · FY 2024
₹1.09 Lakh margin 0.3%
EBITDA · FY 2024
₹14.43 Lakh margin 3.6%

Compounded Annual Growth Rate (CAGR) of Amraph India Private Limited

Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 15%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 24%
5 years · compounded
▲ 17%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 31% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Amraph India Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹14.43 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.09 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Amraph India Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.6%••••••••••••••••
Net Profit Margin0.3%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amraph India are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Amraph India Private Limited

Amraph India Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
S and T Healthcare Technologies Private Limited₹4.02 Cr (FY 2024)••••••••74.0%••••Coimbatore, Tamil Nadu, India
Srisukipharma Private Limited₹4.02 Cr (FY 2024)••••••••79.0%••••Vellore, Tamil Nadu, India
Ezyspit Solutions Private Limited₹4.02 Cr (FY 2022)••••••••1429.0%••••Maratha Hotel Nagpur, Maharashtra, India
Algen Remedies Private Limited₹4.01 Cr (FY 2025)••••••••11.0%••••New Delhi, Delhi, India
Verlen Labs Private Limited₹4.01 Cr (FY 2024)••••••••-18.0%••••Secunderabad, Telangana, India
Amraph India Private Limited this company₹4.01 Cr (FY 2024)••••••••31.0%••••New Delhi, Delhi, India
Vision Ray Health Care Private Limited₹4 Cr (FY 2025)••••••••382.0%••••New Delhi, Delhi, India
Chiron Pharmaceuticals Private Limited₹4 Cr (FY 2024)••••••••11.0%••••Chennai, Tamil Nadu, India
Cure Quick Remedies Private Limited₹4 Cr (FY 2025)••••••••-42.0%••••Haryana, India
Astraazin Pharmaceuticals Private Limited₹4 Cr (FY 2025)••••••••-6.0%••••New Delhi, Delhi, India
Markovate Technologies Private Limited₹4 Cr (FY 2025)••••••••103.0%••••Gurugram, Haryana, India

Peers are the five companies nearest above and the five nearest below Amraph India by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Amraph India Private Limited

Amraph India Private Limited is audited by ASHISH JAIN & CO for the financial year 2019.

NameStatusAppointment DateCessation Date
ASHISH JAIN & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Amraph India Private Limited

Amraph India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anil Kumar KaushikDirector18 Jan 199630 Years 8 MonthsCurrent
Neeru KaushikDirector18 Jan 199630 Years 8 MonthsCurrent

Ownership and Shareholding of Amraph India Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Amraph India Private Limited

Open charges
₹10.18 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.10 Cr
Latest charge details
DateLenderAmountStatus
19 Dec 2022Hdfc Bank Limited₹10.18 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Amraph India Private Limited

Employment history and EPFO contributions of people linked to Amraph India.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Amraph India Private Limited

Amraph India Private Limited has 3 board changes on record since 1996: 2 appointments and 1 cessation. The latest: Vaibhav Kaushik ceased to be Additional Director on 10 Sep 2024.

AGM
Amraph India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Amraph India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Vaibhav Kaushik ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.18 Lakh with Charge ID 100662259 was registered on 19 Dec 2022.
Appointed
Anil Kumar Kaushik was appointed as Director.
Appointed
Neeru Kaushik was appointed as Director.
Incorporation
18 Jan 1996
Amraph India Private Limited was registered on 18 Jan 1996 with Roc Delhi I & aged 30 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Amraph India Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Amraph India Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Amraph India Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Amraph India Private Limited

Amraph India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAACA9872B1ZSDelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Amraph India Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amraph India Private Limited

Amraph India is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 18 January 1996 (30+ years old) and is registered under CIN U51496DL1996PTC075523.

Amraph India reported revenue of ₹4.01 Cr for FY 2024 (up 31% YoY).

Amraph India has 2 current directors:

Amraph India reported a net profit of ₹1.09 Lakh (net margin 0.3%) and EBITDA of ₹14.43 Lakh (EBITDA margin 3.6%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Amraph India is 15% over three years and 6% over five years. In the latest year (FY 2024) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Amraph India is 07AAACA9872B1ZS, registered in Delhi.

The CIN (Corporate Identification Number) of Amraph India is U51496DL1996PTC075523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Amraph India was incorporated on 18 January 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Amraph India by revenue are S and T Healthcare Technologies Private Limited, Srisukipharma Private Limited, Ezyspit Solutions Private Limited, Algen Remedies Private Limited, Verlen Labs Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).

Vaibhav Kaushik ceased to be Additional Director on 10 Sep 2024. Anil Kumar Kaushik was appointed as Director on 18 Jan 1996. Neeru Kaushik was appointed as Director on 18 Jan 1996.

The registered office of Amraph India is at 14 Lalita Park Laxmi Nagar, New Delhi, Delhi, India – 110092.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available